INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Martin van den Bent, M Eoli, JM Sepulveda, Marion Smits, A Walenkamp, J S Frenel, E Franceschi, PM Clement, O Chinot, F Vos, N Whenham, P Sanghera, M Weller, Erik jan Dubbink, Pim French, J Looman, D Dey, S Krause, P Ansell, S NuyensM Spruyt, J Brilhante, C Coens, T Gorlia, V Golfinopoulos

Research output: Contribution to journalArticleAcademicpeer-review

114 Citations (Scopus)
16 Downloads (Pure)
Original languageEnglish
Pages (from-to)684-693
Number of pages10
JournalNeuro-Oncology
Volume22
Issue number5
DOIs
Publication statusPublished - 2020

Research programs

  • EMC MM-03-24-01
  • EMC MM-03-44-06
  • EMC NIHES-03-30-02

Cite this